Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Neeson"'
Autor:
Criselle D’Souza, Simon P. Keam, Han Xian Aw Yeang, Michael Neeson, Kelden Richardson, Andy K. Hsu, Rachael Canfield, Natalie Bezman, Michael Robbins, Hang Quach, David S. Ritchie, Simon J. Harrison, Joseph A. Trapani, H. Miles Prince, Paul A. Beavis, Phillip K. Darcy, Paul J. Neeson
Publikováno v:
Haematologica, Vol 106, Iss 9 (2021)
Externí odkaz:
https://doaj.org/article/ffb9fcdcc42040a99e9894fa282c2f05
Autor:
Joseph A. Trapani, Han Xian Aw Yeang, Paul A. Beavis, Simon J. Harrison, Hang Quach, Rachael Canfield, Criselle D'Souza, H. Miles Prince, Phillip K. Darcy, Simon P. Keam, Natalie Bezman, Paul J Neeson, Kelden Richardson, Andy K Hsu, Michael Neeson, David Ritchie, Michael Robbins
Publikováno v:
Haematologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74162bd5fc51dfa3b600837f9a8bd22
https://doi.org/10.3324/haematol.2020.277525
https://doi.org/10.3324/haematol.2020.277525
Autor:
Ann Byrne, Scott Peterson, Sherene Loi, Franco Caramia, Kylie Clarke, Phillip K. Darcy, Sneha Sant, Michael Neeson, Paul J Neeson, Emmaline Brown, Ran Li
Publikováno v:
Cancer Research. 81:PS10-04
Background: The efficacy of PD-(L)1 inhibitors in patients with trastuzumab-resistant advanced HER2+ breast cancer is poor. Although many HER2 targeted therapies are used clinically, their effect on the tumor immune microenvironment (TME) and whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffe7e268beec486dbfd5f6fe20a45bfc
https://doi.org/10.1158/1538-7445.sabcs20-ps10-04
https://doi.org/10.1158/1538-7445.sabcs20-ps10-04
Autor:
Michael Neeson, Jeanne Butler, Michael H. Kershaw, Joseph A. Trapani, Joe Zhu, Daniela Gm Tantalo, Phil Darcy, Deborah Meyran, Paul J Neeson
Publikováno v:
Cytotherapy. 21:e15-e16
Background & Aim Prostate Cancer (PCa) affects one in six men. Treatment options for men with localized disease include radical prostatectomy or brachytherapy. Unfortunately, patients may also present with advanced PCa which invariably progresses to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f00d3bdd485ca62558f9376cd0c7c7f6
https://doi.org/10.1016/j.jcyt.2019.04.057
https://doi.org/10.1016/j.jcyt.2019.04.057
Autor:
Phillip K. Darcy, Joe Zhu, Daniela Gm Tantalo, Paul G Ekert, Deborah Meyran, Michael Neeson, Michael H. Kershaw, Paul J Neeson, J. Buttler, Joseph A. Trapani
Publikováno v:
Cytotherapy. 21:e15
Background & Aim Refractory solid tumors remain an ongoing clinical problem with significant morbidity and mortality. CAR T cell therapy has the potential to address this issue. However, in contrast to their success in B cell malignancies, CAR T cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d83ae332ff91889de6a1a7a81886619b
https://doi.org/10.1016/j.jcyt.2019.04.050
https://doi.org/10.1016/j.jcyt.2019.04.050